About This Reference Desk

What Gurl Peptide is

Gurl Peptide is an independent editorial reference desk covering the published research on three peptides studied for sexual desire, arousal and the reproductive hormone axis: PT-141, Kisspeptin and Melanotan II, with PT-141 as the lead. The site exists to make a scattered, unevenly covered and frequently overstated literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which species, and how far that evidence reaches.

The organizing idea is direct: these three compounds approach libido, arousal and reproductive signaling from different angles — central melanocortin desire circuits (PT-141), the upstream GnRH axis (Kisspeptin), and broad non-selective melanocortin activity (Melanotan II) — and reading them together gives a fuller, more honest picture than any one alone. Each compound has its own page; a comparison page lines them up side by side; and a single shared references list aggregates every source. Tone is plain and austere. Long sentences give way to short declarative ones. The record is reported at its true strength, including where it is thin, disputed, or carries serious safety cautions.

How it is compiled

Three principles govern what appears on this site.

First, everything is anchored to the peer-reviewed literature. Every research claim is tied to a numbered citation — PubMed-indexed journal articles, clinical trials, regulatory sources and systematic reviews — collected on the references page. Where a finding comes from a review rather than a primary study, the review is cited as such. Citation numbers are stable across the site.

Second, the evidence is reported at its true strength. Doses are described in the species and route in which they were studied — for example, studied at 0.025 mg/kg subcutaneously in men with psychogenic erectile dysfunction — never scaled to humans or offered as a recommendation. Where evidence is Phase 1/2 only, preclinical only, or rests on a single small study, the page says so plainly. Where a safety caution is documented in case reports, it is presented as such, not buried. That candor about limits is the point of the desk.

Third, the three pages are cross-referenced. Because these peptides share a common structural lineage and mechanistic territory, the pages link to one another so a reader can follow how a mechanism — central MC4R desire signaling, for example — evolved from Melanotan II through to PT-141.

What it is not

Gurl Peptide is not a store, not a clinic, and not a source of medical or sexual health advice. It does not sell, supply, source or broker any peptide or research chemical, and it has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule or route of administration for any person, and it never frames an animal-study or clinical-trial dose as something an individual should take.

The peptides discussed here are research compounds. PT-141 has an FDA-approved pharmaceutical form for a narrow indication, but research-grade PT-141 sold online is outside that framework. Kisspeptin is fully investigational. Melanotan II is unapproved and carries serious documented cautions. Readers interested in any condition described in the underlying research should consult a licensed clinician operating within their own jurisdiction. The value this site offers is a calm, accurate map of the literature — nothing more, and nothing it pretends to be.